|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2023
Niederwieser, Dietger 
ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
2022
Ma, Yixuan; Schulz, Benjamin; Trakooljul, Nares; Al Ammar, Moosheer; Sekora, Anett; Sender, Sina; Hadlich, Frieder; Zechner, Dietmar; Weiss, Frank Ulrich; Lerch, Markus M.; Jaster, Robert; Junghanss, Christian und Escobar, Hugo Murua
(2022):
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines.
In: Cancers, Bd. 14, Nr. 18, 4467
Ma, Yixuan; Sender, Sina; Sekora, Anett; Kong, Weibo; Bauer, Peter; Ameziane, Najim; Al-Ali, Ruslan; Krake, Susann; Radefeldt, Mandy; Weiss, Frank Ulrich; Lerch, Markus M.; Parveen, Alisha; Zechner, Dietmar; Junghanss, Christian und Escobar, Hugo Murua
(2022):
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
In: International Journal of Molecular Sciences, Bd. 23, Nr. 8, 4295
Ma, Yixuan; Sender, Sina; Sekora, Anett; Kong, Weibo; Bauer, Peter; Ameziane, Najim; Krake, Susann; Radefeldt, Mandy; Al-Ali, Ruslan; Weiss, Frank Ulrich; Lerch, Markus M.; Parveen, Alisha; Zechner, Dietmar; Junghanss, Christian und Murua Escobar, Hugo
(2022):
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
In: International Journal of Molecular Sciences, Bd. 23, Nr. 8, 4409
Carlet, Michela; Schmelz, Karin; Vergalli, Jenny; Herold, Tobias; Senft, Daniela; Jurinovic, Vindi; Hoffmann, Thomas; Proba, Jutta; Weichert, Nina; Junghanss, Christian; Roth, Mareike; Eschenburg, Georg; Barz, Malwine; Henze, Guenter; Eckert, Cornelia; Eggert, Angelika; Zuber, Johannes; Hundsdoerfer, Patrick und Jeremias, Irmela
(2022):
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
In: EMBO Molecular Medicine, Bd. 15, Nr. 1, e14557
2020
Saussele, Susanne; Haverkamp, Wilhelm; Lang, Fabian; Koschmieder, Steffen; Kiani, Alexander; Jentsch-Ullrich, Kathleen; Stegelmann, Frank; Pfeifer, Heike; La Rosee, Paul; Goekbuget, Nicola; Rieger, Christina; Waller, Cornelius F.; Franke, Georg-Nikolaus; le Coutre, Philipp; Kirchmair, Rudolf und Junghanss, Christian
(2020):
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
In: Acta Haematologica, Bd. 143, Nr. 3: S. 217-231